Home > Healthcare > Medical Devices > Diagnostic Devices > Ingestible Sensors Market

Ingestible Sensors Market Analysis

  • Report ID: GMI8688
  • Published Date: Mar 2024
  • Report Format: PDF

Ingestible Sensors Market Analysis

The market by component is categorized into sensors, wearable patch/data recorder, and software. The sensors segment dominates the market with a revenue of USD 459.4 million in 2023.


  • Sensors that can accurately measure parameters such as temperature, pH levels, pressure, and biomarkers within the gastrointestinal tract are essential for diagnosing conditions like gastrointestinal disorders, acid reflux, and digestive issues. The increasing prevalence of chronic diseases and the growing demand for personalized healthcare solutions drive the demand for ingestible sensors for medical diagnostics and continuous monitoring.


  • Ingestible sensors play a crucial role in drug delivery monitoring by tracking medication adherence, dosage timing, and drug absorption rates within the body. Sensors that can monitor drug release kinetics, detect changes in physiological responses and provide real-time feedback to healthcare providers that can drive growth in this segment, particularly in pharmaceutical research and clinical trials.


The ingestible sensors market by application is categorized into medical and sports and fitness. The medical segment accounted for majority revenue share and was valued at USD 631.7 million in 2023.


  • Ingestible sensors are used for different purposes in the medical domain including remote patient monitoring, disease diagnostic, treatment optimization, and personalized medicine, among others. For example, these sensors support the ongoing shift towards personalized medicine by providing real-time data on individual patient responses to treatment. Sensors that can collect and analyze physiological data, identify biomarkers, and predict disease risk enable personalized treatment approaches tailored to each patient's unique needs, preferences, and genetic makeup.


  • Additionally, ingestible sensors are notably used by pharmaceutical companies in clinical research and trials to collect objective data on drug efficacy, patient response to treatment, and disease progression. Sensors that can monitor patient outcomes, adherence to study protocols, and adverse events facilitate data-driven decision-making, accelerate drug development, and improve clinical trials efficiency.


Ingestible Sensors Market, By End-use (2023)

The ingestible sensors market by end-use is categorized into hospitals and clinics, sports and fitness centers, pharmaceutical companies, and other end-users. The hospitals and clinics segment exceeded USD 408.7 million in 2023.


  • Ingestible sensors are used to monitor medication adherence and track drug absorption rates in patients with chronic medical conditions such as inflammatory bowel disease (IBD), diabetes, and cardiovascular disease. Sensors embedded in oral medications transmit real-time data on medication ingestion, dosage timing, and drug release kinetics, enabling healthcare providers in hospitals and clinics to optimize treatment regimens and improve therapeutic outcomes.


  • Moreover, ingestible camera capsules, also known as capsule endoscopy, are used for non-invasive imaging of the gastrointestinal tract. These capsules contain miniature cameras that capture high-resolution images as they pass through the digestive system, allowing healthcare providers to visualize the esophagus, stomach, small intestine, and colon for the detection of abnormalities such as ulcers, polyps, and tumors.


North America Ingestible Sensors Market, 2022- 2032 (USD Million)

North America ingestible sensors market accounted for USD 355.6 million revenue in 2023 and is predicted to witness substantial market growth.


  • There is a growing awareness among consumers in North America about the benefits of digital health technologies, including ingestible sensors, for personalized healthcare and wellness management. Increased consumer adoption of wearable devices, smartphone apps, and telemedicine platforms that integrate ingestible sensor data further drives demand for these sensors in the region.


  • Additionally, there is a significant demand and growing trend of fitness and sports related activities and developments in the region. These sensors are increasingly being used in sports and fitness applications for monitoring hydration levels, electrolyte balance, and performance metrics during physical activity.


  • Sensors that can provide actionable insights into an individual's physiological responses to exercise, optimize training regimens, and prevent dehydration or overexertion can drive demand in this segment, particularly among athletes, sports teams, and fitness enthusiasts.
Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Ingestible sensors market size was USD 849.7 million in 2023 and is expected to register 9.2% CAGR from 2024-2032 owing to the growing shift towards preventive healthcare, increase in R&D activities and investments, and supportive regulatory guidelines worldwide.

The sensors segment recorded USD 459.4 million in 2023 and is expected to register an appreciable CAGR from 2024-2032 due to increasing prevalence of chronic diseases and the growing demand for personalized healthcare solutions.

North America ingestible sensors industry reached USD 355.6 million in 2023 due to growing awareness among consumers, about the benefits of digital health technologies, including ingestible sensors, for personalized healthcare and wellness management in the region.

BodyCAP, CapsoVision, Inc., Check-Cap, etectRx, IntroMedic, JINSHAN Science & Technology, Koninklijke Philips N.V., Medtronic plc, Olympus Corporation, and Otsuka Holdings Co., Ltd., are some of the major ingestible sensors companies worldwide.

Ingestible Sensors Market Scope

Buy Now

Premium Report Details

  • Base Year: 2023
  • Companies covered: 10
  • Tables & Figures: 248
  • Countries covered: 22
  • Pages: 140
 Download Free Sample